Business Wire

HERMAN-MILLER

11.1.2023 14:31:39 CET | Business Wire | Press release

Share
Herman Miller Continues Expansion of Pioneering Use of Ocean-Bound Plastic With Updated Sayl Chair

Herman Miller is continuing to increase the use of ocean-bound plastic within the modern furniture maker’s portfolio. The Sayl Chair, designed by esteemed Swiss Designer Yves Béhar will now include up to 1.36 kg (3 pounds) of mismanaged plastic waste found near waterways. This change builds upon the momentum created by the introduction of ocean-plastic in the iconic Aeron Chair in 2021 and will divert 95 metric tons*, the equivalent of approximately 9.6 million plastic water bottles, from the ocean annually.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230111005101/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Herman Miller Continues Expansion of Pioneering Use of Ocean-Bound Plastic With Updated Sayl Chair (Photo: Business Wire)

As part of the MillerKnoll collective, today’s announcement highlights Herman Miller’s ongoing commitment to sustainability, and long-term goal to increase recycled content to at least 50 percent, including the use of ocean-bound plastic, across all material the Company uses by 2030.

Sayl joins an impressive roster of Herman Miller products now being made with ocean-bound plastic. Between Aeron, Sayl, and other product lines including OE1 and Revenio textiles, the Company estimates that 234 metric tons of ocean-bound plastic, the equivalent of 23 million water bottles, will be diverted from the ocean annually.

“True innovation isn’t always about making new products,” says Gabe Wing, Director of Sustainability at MillerKnoll. “Oftentimes it can be looking for ways to use new research, perspectives, and resources to improve what already exists. Our team is incredibly excited to continue to improve and introduce products that promote responsible use of Earth’s resources.”

Since its introduction in 2010, the Sayl chair has been a leader in responsible design. Inspired by the Golden Gate Bridge, the eco-dematerialized design of Sayl was specifically created to use less material in inventive ways while providing ergonomic support and comfort. Additionally, the chair is 92% recyclable at the end of life.

Yves Béhar, the designer of Sayl and founder of fuseproject, commented on the announcement: “Charles Eames once said ‘Design is never done.’ That is true for the Sayl chair as improvements continue to be made years and years after launch. It was designed from the start as a light, simple, and lower carbon footprint chair in the full-featured task chairs category. And now, years after its launch I’m excited to see Sayl manufactured in recycled plastic diverted from rivers and oceans as the next step in bettering the design. At fuseproject, that has always been a focus and passion, and will continue to be central to our work.”

All colours of the Sayl chair will include ocean-bound plastic, which will grow to include the special edition versions created for Herman Miller Gaming in the future. Depending on the color chosen, each Sayl will have between .907kg (2 pounds) and 1.36kg (3 pounds) of ocean-bound plastic incorporated, with the Black version of Sayl having the highest. Sayl with ocean-bound plastic is available in Europe now and will be available in other areas of the globe later in 2023.

Herman Miller also announced that all colours of the Aeron are now available with ocean-bound plastic starting in November. The Onyx, Graphite, Mineral, and Carbon colours contain up to 1.13 kg (2.5 pounds) of ocean-bound plastic per chair.

To learn more about the specific environmental information for each variation of the Sayl or Aeron Chairs and to see how purchasing these items can contribute to green building standards including LEED, please visit https://millerknoll.ecomedes.com/.

About Herman Miller

Since 1905, Herman Miller has been guided by a commitment to problem-solving designs that inspire the best in people. Along the way, Herman Miller has forged critical relationships with the most visionary designers of the day, from midcentury greats like George Nelson, the Eames Office, and Isamu Noguchi, to research-oriented visionaries like Robert Propst and Bill Stumpf — and with today’s groundbreaking studios like Industrial Facility and Studio 7.5. From the birth of ergonomic furniture to manufacturing some of the twentieth century’s most iconic pieces, Herman Miller has spent the last century pioneering original, timeless design that makes an enduring impact, while building a lasting legacy of design, innovation and social good. Herman Miller is a part of MillerKnoll, a collective of dynamic brands that comes together to design the world we live in.

*Based on current selling forecasts.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230111005101/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 15:29:00 CET | Press release

Pending the European Commission decision, Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) will be the first PD-1 immunotherapy treatment for patients with advanced squamous cell carcinoma of the anal canal (SCAC) in EuropeGlobally, the prevalence of SCAC is estimated at around 1 or 2 cases per 100,000 people, with a higher incidence in women than in men1,2,3The Committee for Medicinal Products for Human Use (CHMP) positive opinion is based on data from the Phase 3 POD1UM-303/InterAACT2 trial which showed patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment4 Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (

Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 13:32:00 CET | Press release

Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,

BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 09:00:00 CET | Press release

The Latest Players and AI Capabilities Drive Captivating, Personalized, and Interactive Signage With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerfu

Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 08:30:00 CET | Press release

Iconic Vbeam® Pro and Matrix™ Systems showcased ahead of broader commercial availability Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, suppo

Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 08:00:00 CET | Press release

Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets.​ “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.”​ Throughout his career, Dan has held senior leadership roles i

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye